Clovis Oncology Announces Clinical Data to be Presented at American Society of Clinical Oncology Annual Meeting 2013
Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!
Clovis Oncology (NASDAQ:CLVS) announced that three abstracts (ASCO Abstracts #2524, #2585, #2586) highlighting results from three Phase I studies of the company’s two lead compounds will be presented at the American Society of Clinical Oncology (ASCO) Annual Meeting 2013 in Chicago.
Help employers find you! Check out all the jobs and post your resume.
Clovis Oncology (NASDAQ:CLVS) announced that three abstracts (ASCO Abstracts #2524, #2585, #2586) highlighting results from three Phase I studies of the company’s two lead compounds will be presented at the American Society of Clinical Oncology (ASCO) Annual Meeting 2013 in Chicago.
Help employers find you! Check out all the jobs and post your resume.